Directorate Change
![](https://tracker.live.rns-distribution.com/track.live-rns/5516010_d9353a075fe0b610698e373da828b7e4.png)
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Board changes
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.
Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.
Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.
Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.
"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."
Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."
Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."
In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:
Current directorships / partnerships | Previous directorships / partnerships in last 5 years |
Alliance Pharma plc | Global Diagnostics Ireland Ltd |
C4X Discovery Holdings Limited | Global Retinopathy Screening Ltd |
Hampshire Topco Limited | JCA Seminars Limited |
Hero Acquisitions Limited | Medica Australia Pty Ltd |
HSS Hire Group plc | Medica Group Limited |
HSS Hire Service Finance Limited | Medica IT Services Limited |
RCMJ Consultancy Ltd | Medica Reporting Finance Limited |
Medica Reporting Limited | |
Medica Reporting Services Limited | |
Medica US Inc | |
Med-IDX Pty Ltd | |
Med-IDX UK Limited | |
Mereo Biopharma 1 Limited | |
Mereo Biopharma 2 Limited | |
Mereo Biopharma 3 Limited | |
Mereo Biopharma 4 Limited | |
Mereo Biopharma Group plc | |
Mereo BioPharma Ireland Limited | |
Mereo MereoCo Inc | |
Mereo US Holdings Inc | |
Moonlight Bidco Limited | |
Moonlight Midco 1 Limited | |
Moonlight Midco 2 Limited | |
Moonlight Topco Limited |
Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.
For further information, please contact:
Inspiration Healthcare Group plc | Tel: +44 (0)330 175 0000 |
Roy Davis, Executive Chair Alan Olby, Chief Financial Officer | |
Panmure Liberum (Nominated Adviser & Broker) | Tel: +44 (0)20 3100 2000 |
Richard Lindley Will King | |
| |
Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
Anna Dunphy | Mob: +44 (0) 7876 741 001 |
Louis Ashe-Jepson | Mob: +44 (0) 7747 515 393 |
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.